Research Poster: Hoxb8-derived anti-GPC3 CAR expressing macrophages as a preclinical model for HCC immunotherapies

My research project involved engineering macrophages from Hoxb8 progenitors to express a GPC3-specific CAR for targeting hepatocellular carcinoma. The cells retained macrophage identity and CAR expression, offering a scalable platform to develop macrophage-based immunotherapies for HCC.
Research Poster: Hoxb8-derived anti-GPC3 CAR expressing macrophages as a preclinical model for HCC immunotherapies
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

Please sign in

If you are a registered user on Laidlaw Scholars Network, please sign in